Log in

Relevant bibliographies by topics / Anticancer chemotherapy / Books

To see the other types of publications on this topic, follow the link: Anticancer chemotherapy.

Books on the topic 'Anticancer chemotherapy'

Author: Grafiati

Published: 28 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 49 books for your research on the topic 'Anticancer chemotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Wani, Mohmmad Younus, and Manzoor Ahmad Malik. Gold and its Complexes in Anticancer Chemotherapy. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6314-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Macromolecular anticancer therapeutics. New York: Springer Verlag, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Laurell, Göran. Ototoxicity of the anticancer drug cisplatin: Clinical and experimental aspects. Stockholm, Sweden: Distributed by Almqvist & Wiksell Periodical Co., 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Avendaño, Carmen. Medicinal chemistry of anticancer drugs. Amsterdam: Elsevier, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

J, Houghton Peter, and Houghton Janet A, eds. Preclinical and clinical modulation of anticancer drugs. Boca Raton: CRC Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lipp, H. P. Prevention and management of anticancer drug toxicity: The significance of clinical pharmacokinetics. Jena: Univ.-Verlag, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

International, Interface of "Clinical and Laboratory Responses to Anticancer Drugs" (1st 1989 Villejuif France). Anticancer drugs : proceedings of the first International Interface of "Clinical and Laboratory Responses to Anticancer Drugs," March 13th-15th, 1989, Villejuif, France =: Médicaments anticancéreux : actes de la première confrontation internationale des "Réponses cliniques et expérimentales aux médicaments anticancéreux" 13-15 Mars 1989, Villejuif, France. Paris: INSERM, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

International Interface of "Clinical and Laboratory Responses to Anticancer Drugs" (1st 1989 Villejuif, France). Anticancer drugs: Proceedings of the first International Interface of "Clinical and Laboratory Responses to Anticancer Drugs," March 13th-15th, 1989, Villejuif, France = Médicaments anticancéreux : actes de la première confrontation internationale des "Réponses cliniques et expérimentales aux médicaments anticancéreux," 13-15 Mars 1989, Villejuif, France. Edited by Lampidis T. J, Robert Jacques M. D, Tapiero H, and Institut national de la santé et de la recherche médicale (France). Paris, France: Editions INSERM ; London : J. Libbey Eurotext, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zhong yao kang ai huo xing cheng fen: Anticancer active components in TCM. Beijing: Ke xue chu ban she, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

P, Hacker Miles, Lazo John S, and Tritton Thomas R, eds. Organ directed toxicities of anticancer drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of Anticancer Drugs, Burlington, Vermont, USA, June 4-6, 1987. Boston: Nijhoff, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Lien, Eric J. Structure-activity relationship analysis of Chinese anticancer drugs and related plants. Long Beach, CA., U.S.A: Oriental Healing Arts Institute, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Lien, Eric J. Structure-activity relationship analysis of Chinese anticancer drugs and related plants. Long Beach, CA., U.S.A: Oriental Healing Arts Institute, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

International Symposium on Novel Approaches in Cancer Therapy (1993 Heidelberg, Germany). Novel approaches in anticancer drug design: Molecular modelling, new treatment strategies : International Symposium on Novel Approaches in Cancer Therapy, Heidelberg, December 1-4, 1993. Edited by Zeller W. J, D'Incalci Maurizio, and Newell David R. Basel: Karger, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Hong, Sŏn-pʻyo. Hanbang cheje ro putʻŏ hangamje ŭi kaebal: Hanbang chʻiryo kisul yŏnʼgu kaebal saŏp chʻoejong pogosŏ = Development of anticancer agent from the preparation of oriental medical extracts. [Kyŏnggi-do Kwachʻŏn-si]: Pogŏn Pokchibu, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Frederick, Valeriote, and Baker Laurence H, eds. Biochemical modulation of anticancer agents: Experimental and clinical approaches : proceedings of the 18th Annual Detroit Cancer Symposium, Detroit, Michigan, USA, June 13-14, 1986. Boston: Nijhoff, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

(Editor), Haim Tapiero, Jacques Robert (Editor), and Theodore J. Lampidis (Editor), eds. Anticancer Drugs. John Libbey & Co Ltd, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

The anticancer drugs. 2nd ed. Oxford: OxfordUniversity Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

1938-, Pratt William B., and Pratt William B. 1938-, eds. The anticancer drugs. 2nd ed. New York: Oxford University Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Recent Advances in Chemotherapy: Anticancer Section. Columbia University Press, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

1945-, Ojima Iwao, Vite Gregory D, Altmann Karl-Heinz, American Chemical Society. Division of Organic Chemistry, American Chemical Society. Division of Medicinal Chemistry, and American Chemical Society Meeting, eds. Anticancer agents: Frontiers in cancer chemotherapy. Washington, DC: American Chemical Society, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sotiris, Missailidis, ed. Anticancer therapeutics. Chichester: John Wiley & Sons, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Missailidis, Sotiris. Anticancer Therapeutics. Wiley & Sons, Incorporated, John, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

1950-, Georgopapadakou Nafsika H., ed. Drug transport in antimicrobial and anticancer chemotherapy. New York: Marcel Dekker, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Camptothecins New Anticancer Agents. CRC Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

(Editor), Bruce C. Baguley, and David J. Kerr (Editor), eds. Anticancer Drug Development. Academic Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hildebrand, Jerzy. Neurological Adverse Reactions to Anticancer Drugs. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kim, Se-Kwon. Handbook of Anticancer Drugs from Marine Origin. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Campanati, Anna, Annamaria Offidani, and Giulia Ganzetti. New Skin Toxicities for New Anticancer Therapies. Nova Science Publishers, Incorporated, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

(Editor), Iwao Ojima, Gregory D. Vite (Editor), and Karl-Heinz Altmann (Editor), eds. Anticancer Agents: Frontiers in Cancer Chemotherapy (Acs Symposium Series). An American Chemical Society Publication, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Powis, Garth. Metabolism & Action of AntiCancer Drugs. Taylor & Francis, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

1946-, Lippert Bernhard, ed. Cisplatin: Chemistry and biochemistry of a leading anticancer drug. Zürich: Verlag Helvetica Chimica Acta, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

(Editor), Bruce C. Baguley, and David J. Kerr (Editor), eds. Anticancer Drug Development. Academic Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

J, Waring Michael, and Ponder, B. A. J. 1944-, eds. The Search for new anticancer drugs. Dordrecht: Kluwer Academic Publishers, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Astrid, Sigel, and Sigel Helmut, eds. Metal complexes in tumor diagnosis and as anticancer agents. New York: Marcel Dekker, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

1964-, Spencer Peter, and Holt Walter, eds. Anticancer drugs: Design, delivery and pharmacology. Hauppauge, NY: Nova Science Publishers, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Medicinal Chemistry of Anticancer Drugs. Elsevier Science & Technology Books, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Medicinal Chemistry of Anticancer Drugs. Elsevier Science, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

J, Hildebrand, ed. Neurological adverse reactions to anticancer drugs. Berlin: Springer-Verlag, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

(Editor), Joachim G. Liehr, Beppino C. Giovanella (Editor), and Claire F. Verschraegen (Editor), eds. The Camptothecins: Unfolding Their Anticancer Potential (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Organ Directed Toxicities of Anticancer Drugs (Developments in Oncology). Springer, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches (Developments in Oncology). Springer, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Pharmacogenomics, Anticancer Drug Discovery, and Response (Cancer Drug Discovery and Development). Humana Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Metal Ions in Biological Systems: Volume 42: Metal Complexes in Tumor Diagnosis and as Anticancer Agents (Metal Ions in Biological Systems). CRC, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Fiebig, H. H. Revelance Of Tumor Models For Anticancer Drug Development (CONTRIBUTIONS TO ONCOLOGY). Edited by H. H. Fiebig. Karger, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Freifeld, Alison G. An Introduction. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199938568.003.0100.

Full text

Abstract:

This chapter focuses on solid tumors and how they can be treated. Solid tumors, lymphomas, and leukemias represent a widely diverse array of cancers. Until recently, the general approach to treating all of them was to administer cytotoxic anticancer drugs that damage proliferating cells by interfering with mitosis and other essential steps in cellular replication. Localized solid tumors are largely treated by surgical resection and radiotherapy, with cytotoxic chemotherapy being commonly used adjunctively or in cases of metastatic disease. A major drawback of this approach has been the lack of specificity in that cytotoxic drugs will destroy actively dividing normal cells as well as malignant cells. The “shotgun approach” of using intensive cytotoxic chemotherapies has been the mainstay of cancer treatment for at least 6 decades. The chapter concludes that in addition to the tissue damage and immunomodulating effects of anticancer drugs, it should be remembered that cancers themselves may increase the chances for infection.

APA, Harvard, Vancouver, ISO, and other styles

46

(Editor), W. J. Zeller, G. Eisenbrand (Editor), and K. Hellmann (Editor), eds. Reduction of Anticancer Drug Toxicity: Pharmacologic, Biologic, Immunologic and Gene Therapeutic Approaches (Contributions to Oncology, Vol 48). S. Karger AG (Switzerland), 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Innominato, Pasquale F., and David Spiegel. Circadian rhythms, sleep, and anti-cancer treatments. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198778240.003.0016.

Full text

Abstract:

The circadian timing system temporally regulates biological functions relevant for psycho-physical wellbeing, spanning all the systems related to health. Hence, disruption of circadian rhythms, along with sleep cycles, is associated with the development of several diseases, including cancer. Moreover, altered circadian and sleep functions negatively impact on cancer patients’ quality of life and survival, above and beyond known determinants of outcome. This alteration can occur as a consequence of cancer, but also of anti-cancer treatments. Indeed, circadian rhythms govern also the ability of detoxifying chemotherapy agents across the 24 hours. Hence, adapting chemotherapy delivery to the molecular oscillations in relevant drug pathways can decrease toxicity to healthy cells, while increasing the number of cancer cells killing. This chronomodulated chemotherapy approach, together with the maintenance of proper circadian function throughtout the whole disease challenge, would finally result in safer and more active anticancer treatments, and in patients experiencing better quality and quantity of life.

APA, Harvard, Vancouver, ISO, and other styles

48

Ripamonti, Carla I., Alexandra M. Easson, and Hans Gerdes. Bowel obstruction. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656097.003.0143.

Full text

Abstract:

In this chapter, malignant bowel obstruction is defined as the clinical presentation of patients with symptoms, signs, and radiographic evidence of obstruction to the transit of gastrointestinal contents caused by cancer, or the consequences of anticancer therapy including surgery, chemotherapy, or radiation therapy. Malignant bowel obstruction secondary to cancer or its treatments is encountered relatively frequently in supportive care as well as in in hospice/palliative care practice, carries a poor prognosis, and is associated with significant symptoms. Careful clinical assessment and an understanding of the patient’s disease trajectory are crucial in recommending the best way of providing palliation. In someone with a single-level obstruction and good functional status, surgery should be offered. Those with multilevel obstruction are almost never surgical candidates and should be managed with changes in oral intake and medications.

APA, Harvard, Vancouver, ISO, and other styles

49

Stephen, Neidle, and Waring Michael J, eds. Molecular aspects of anticancer drug-DNA interactions. Boca Raton: CRC, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!